News
A nationwide Danish cohort study demonstrated no increased risk of serious adverse events following vaccination with JN.1-updated mRNA COVID-19 vaccines, reinforcing their safety profile and ...
U.S. kindergarten vaccination rates inched down again last year and the share of children with exemptions rose to an all-time ...
The COVID-19 pandemic upended life for individuals and communities worldwide. Social isolation, health mandates, illness, and economic hardships took ...
The global healthcare industry stands at a crossroads. With over 4.2 billion people relying on digital health services, ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
A global study on the neurological effects of the COVID-19 vaccine reveals key trends, with the U.S. leading in publications ...
The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...
Texas medical freedom advocates have been pushing against vaccine requirements and recommendations for years. Now, they're in ...
Your premium access has ended, but the best of Nation.Africa is still within reach. Renew now to unlock exclusive stories and ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...
Analysts say the departure of the CBER head may alleviate overhang in the cell and gene therapy space. Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and ...
The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results